Sinofn Health
Sinofn Health
SINOFN Health Co., Ltd., established in 2025 (tracing roots to 2012), operates as a premier supplement OEM manufacturing partner. Unlike traditional contract manufacturers, we are a science-driven enterprise backed by the Chinese Academy of Sciences. We bridge the gap between clinical research and commercial scalability, ensuring our partners receive not just products, but actionable market advantages.
Founded by Mrs. GuoHong Liu, our journey began with a noble mission: addressing Phenylketonuria (PKU) accessibility. This legacy of "Purpose-Driven Innovation" continues today, where we apply the same rigor of special medical food development to our entire portfolio, ranging from daily wellness supplements to complex bioactive formulations.
In an era of global supply uncertainty, SINOFN provides the stability of "Factory 4.0". We utilize automated production lines, blockchain-based batch tracking, and full-plant integration. This ensures that every unit produced—from powder to gummies—adheres to strict ISO 22000, HACCP, and FSSC 22000 standards. Our infrastructure supports an annual capacity of over 500 million units, ensuring scalability for both agile startups and large-scale global enterprises.
The future of nutraceuticals lies in "Bio-availability Optimization". Our R&D center, spearheaded by experts like Dr. Zhang Ying (CAS Postdoc) and Hans van Dijk (EU Regulatory Specialist), focuses on next-generation delivery systems. We are currently pioneering the use of micro-encapsulation and targeted release technologies for cAMP, cognitive health, and sports nutrition sectors. We don't just manufacture; we co-create the products of tomorrow.
Medical Innovation Director
Ph.D. Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead
Associate Researcher, CAS Postdoc. Specialist in bioactive compound delivery systems.
Formulation Director
Senior Scientist (Netherlands). EU regulatory specialist in nutraceutical delivery tech.
Navigating international food supplement regulations is the greatest barrier for brands. At SINOFN, we eliminate this friction. By employing international experts like Mr. Hans van Dijk, we ensure our production standards align with EU, US, and local regulatory frameworks. Our certification portfolio—including ISO9001, ISO22000, HACCP, and HALAL—demonstrates our unwavering commitment to quality and safety. We offer comprehensive support, including stability testing, microbiological screening, and full documentation to assist our global partners in seamless market entry.
A: Our operations are centralized in China, leveraging cutting-edge manufacturing zones that provide access to world-class logistics, R&D talent, and supply chain infrastructure, serving global regions effectively.
A: Absolutely. Our Tianjin R&D center is specifically designed for pilot-scale prototyping for tablets, capsules, and liquids, allowing for bioavailability optimization before full-scale production.
A: Yes. We offer tailored manufacturing scopes that scale with your business, from specialized small-batch pilot runs for startups to massive production capabilities for multinational brands.
